• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 251/18 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Patent holdings for IPC class C07D 251/18

Total number of patents in this class: 182

10-year publication summary

10
27
8
14
9
9
11
5
11
4
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Servier Pharmaceuticals, LLC
104
17
BASF SE
20933
14
Agios Pharmaceuticals, Inc
216
7
Emory University
1626
7
Anji Pharmaceuticals Inc.
34
7
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
702
6
Centaurus Biopharma Co., Ltd.
82
5
Lianyungang Runzhong Pharmaceutical Co., Ltd.
84
5
Pfizer Inc.
3387
4
Luoda Biosciences, Inc.
6
4
Aluda Pharmaceuticals, Inc.
5
4
Bayer Cropscience AG
2035
3
Takeda Pharmaceutical Company Limited
2713
3
Betta Pharmaceuticals Co., Ltd.
179
3
The United States Government AS represented by The Department of Veterans Affairs
1174
3
University of Basel
42
3
AstraZeneca AB
2909
2
Centre National de La Recherche Scientifique
10418
2
Astellas Pharma Inc.
1088
2
Borealis Agrolinz Melamine GmbH
24
2
Other owners 79